> top > docs > PMC:2674207 > spans > 37398-37795 > annotations

PMC:2674207 / 37398-37795 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T11698 0-4 RB denotes Thus
T11699 4-5 -COMMA- denotes ,
T11700 6-13 VB denotes inhaled
T11701 14-16 NN denotes FP
T11702 17-18 -LRB- denotes (
T11703 18-21 CD denotes 500
T11704 22-24 NN denotes µg
T11705 24-25 -RRB- denotes )
T11706 26-33 VB denotes induced
T11707 34-45 JJ denotes significant
T11708 46-50 NN denotes loss
T11709 51-53 IN denotes in
T11710 54-61 JJ denotes nuclear
T11711 62-68 NN denotes GATA-3
T11712 69-71 IN denotes at
T11713 72-73 CD denotes 2
T11714 74-75 NN denotes h
T11715 76-77 -LRB- denotes (
T11716 77-83 NN denotes median
T11717 84-85 -LRB- denotes [
T11718 85-87 CD denotes 95
T11719 87-88 NN denotes %
T11720 89-91 NN denotes CI
T11721 91-92 -RRB- denotes ]
T11722 92-93 -COMMA- denotes ,
T11723 94-98 CD denotes 0.40
T11724 99-100 -LRB- denotes [
T11725 100-109 CD denotes 0.27–0.53
T11726 109-110 -RRB- denotes ]
T11727 111-117 IN denotes versus
T11728 118-122 CD denotes 0.14
T11729 123-124 -LRB- denotes [
T11730 124-133 CD denotes 0.11–0.19
T11731 133-134 -RRB- denotes ]
T11732 134-135 -COMMA- denotes ,
T11733 136-137 NN denotes p
T11734 137-138 SYM denotes <
T11735 138-142 CD denotes 0.05
T11736 142-143 -COMMA- denotes ,
T11737 144-153 NN denotes W = 21.00
T11738 153-154 -COMMA- denotes ,
T11739 155-163 NNP denotes Wilcoxon
T11740 163-165 POS denotes 's
T11741 166-170 NN denotes rank
T11742 171-175 NN denotes test
T11743 175-176 -RRB- denotes )
T11744 177-178 -LRB- denotes (
T11745 178-184 NN denotes Figure
T11746 185-187 NN denotes 7C
T11747 187-188 -RRB- denotes )
T11748 189-192 CC denotes and
T11749 193-204 JJ denotes cytoplasmic
T11750 205-211 NN denotes GATA-3
T11751 212-218 NN denotes levels
T11752 219-223 VB denotes were
T11753 224-232 VB denotes enhanced
T11754 233-235 IN denotes by
T11755 236-243 VB denotes inhaled
T11756 244-246 NN denotes FP
T11757 247-249 IN denotes in
T11758 250-251 DT denotes a
T11759 252-266 JJ denotes dose-dependent
T11760 267-273 NN denotes manner
T11761 274-275 -LRB- denotes (
T11762 275-281 NN denotes median
T11763 282-283 -LRB- denotes [
T11764 283-285 CD denotes 95
T11765 285-286 NN denotes %
T11766 287-289 NN denotes CI
T11767 289-290 -RRB- denotes ]
T11768 290-291 -COMMA- denotes ,
T11769 292-298 CD denotes 0.0032
T11770 299-300 -LRB- denotes [
T11771 300-313 CD denotes 0.0026–0.0039
T11772 313-314 -RRB- denotes ]
T11773 315-321 IN denotes versus
T11774 322-327 CD denotes 0.658
T11775 328-329 -LRB- denotes [
T11776 329-340 CD denotes 0.592–0.720
T11777 340-341 -RRB- denotes ]
T11778 341-342 -COMMA- denotes ,
T11779 343-344 NN denotes p
T11780 344-345 SYM denotes <
T11781 345-349 CD denotes 0.05
T11782 349-350 -COMMA- denotes ,
T11783 351-361 NN denotes W = −21.00
T11784 361-362 -COMMA- denotes ,
T11785 363-371 NNP denotes Wilcoxon
T11786 371-373 POS denotes 's
T11787 374-378 NN denotes rank
T11788 379-383 NN denotes test
T11789 383-384 -RRB- denotes )
T11790 385-386 -LRB- denotes (
T11791 386-392 NN denotes Figure
T11792 393-395 NN denotes 7D
T11793 395-396 -RRB- denotes )
R10037 T11701 T11700 arg2Of FP,inhaled
R10038 T11701 T11702 arg1Of FP,(
R10039 T11701 T11706 arg1Of FP,induced
R10040 T11704 T11702 arg2Of µg,(
R10041 T11704 T11703 arg1Of µg,500
R10042 T11705 T11702 arg3Of ),(
R10043 T11706 T11748 arg1Of induced,and
R10044 T11708 T11706 arg2Of loss,induced
R10045 T11708 T11707 arg1Of loss,significant
R10046 T11708 T11709 arg1Of loss,in
R10047 T11708 T11712 arg1Of loss,at
R10048 T11708 T11715 arg1Of loss,(
R10049 T11708 T11744 arg1Of loss,(
R10050 T11711 T11709 arg2Of GATA-3,in
R10051 T11711 T11710 arg1Of GATA-3,nuclear
R10052 T11714 T11712 arg2Of h,at
R10053 T11714 T11713 arg1Of h,2
R10054 T11716 T11715 arg2Of median,(
R10055 T11716 T11717 arg1Of median,[
R10056 T11716 T11722 arg1Of median,","
R10057 T11716 T11732 arg1Of median,","
R10058 T11718 T11719 arg1Of 95,%
R10059 T11720 T11717 arg2Of CI,[
R10060 T11720 T11718 arg1Of CI,95
R10061 T11721 T11717 arg3Of ],[
R10062 T11723 T11722 arg2Of 0.40,","
R10063 T11723 T11724 arg1Of 0.40,[
R10064 T11723 T11727 arg1Of 0.40,versus
R10065 T11725 T11724 arg2Of 0.27–0.53,[
R10066 T11726 T11724 arg3Of ],[
R10067 T11728 T11727 arg2Of 0.14,versus
R10068 T11728 T11729 arg1Of 0.14,[
R10069 T11730 T11729 arg2Of 0.11–0.19,[
R10070 T11731 T11729 arg3Of ],[
R10071 T11733 T11732 arg2Of p,","
R10072 T11733 T11734 arg1Of p,<
R10073 T11733 T11735 arg1Of p,0.05
R10074 T11733 T11736 arg1Of p,","
R10075 T11733 T11738 arg1Of p,","
R10076 T11737 T11736 arg2Of W = 21.00,","
R10077 T11739 T11740 arg2Of Wilcoxon,'s
R10078 T11742 T11738 arg2Of test,","
R10079 T11742 T11740 arg1Of test,'s
R10080 T11742 T11741 arg1Of test,rank
R10081 T11743 T11715 arg3Of ),(
R10082 T11746 T11744 arg2Of 7C,(
R10083 T11746 T11745 arg1Of 7C,Figure
R10084 T11747 T11744 arg3Of ),(
R10085 T11748 T11698 arg1Of and,Thus
R10086 T11748 T11699 arg1Of and,","
R10087 T11751 T11749 arg1Of levels,cytoplasmic
R10088 T11751 T11750 arg1Of levels,GATA-3
R10089 T11751 T11752 arg1Of levels,were
R10090 T11751 T11753 arg2Of levels,enhanced
R10091 T11753 T11748 arg2Of enhanced,and
R10092 T11753 T11752 arg2Of enhanced,were
R10093 T11753 T11757 arg1Of enhanced,in
R10094 T11756 T11753 arg1Of FP,enhanced
R10095 T11756 T11754 arg2Of FP,by
R10096 T11756 T11755 arg2Of FP,inhaled
R10097 T11760 T11757 arg2Of manner,in
R10098 T11760 T11758 arg1Of manner,a
R10099 T11760 T11759 arg1Of manner,dose-dependent
R10100 T11760 T11761 arg1Of manner,(
R10101 T11760 T11790 arg1Of manner,(
R10102 T11762 T11761 arg2Of median,(
R10103 T11762 T11763 arg1Of median,[
R10104 T11762 T11768 arg1Of median,","
R10105 T11762 T11778 arg1Of median,","
R10106 T11764 T11765 arg1Of 95,%
R10107 T11766 T11763 arg2Of CI,[
R10108 T11766 T11764 arg1Of CI,95
R10109 T11767 T11763 arg3Of ],[
R10110 T11769 T11768 arg2Of 0.0032,","
R10111 T11769 T11770 arg1Of 0.0032,[
R10112 T11769 T11773 arg1Of 0.0032,versus
R10113 T11771 T11770 arg2Of 0.0026–0.0039,[
R10114 T11772 T11770 arg3Of ],[
R10115 T11774 T11773 arg2Of 0.658,versus
R10116 T11774 T11775 arg1Of 0.658,[
R10117 T11776 T11775 arg2Of 0.592–0.720,[
R10118 T11777 T11775 arg3Of ],[
R10119 T11779 T11778 arg2Of p,","
R10120 T11779 T11780 arg1Of p,<
R10121 T11779 T11781 arg1Of p,0.05
R10122 T11779 T11782 arg1Of p,","
R10123 T11779 T11784 arg1Of p,","
R10124 T11783 T11782 arg2Of W = −21.00,","
R10125 T11785 T11786 arg2Of Wilcoxon,'s
R10126 T11788 T11784 arg2Of test,","
R10127 T11788 T11786 arg1Of test,'s
R10128 T11788 T11787 arg1Of test,rank
R10129 T11789 T11761 arg3Of ),(
R10130 T11792 T11790 arg2Of 7D,(
R10131 T11792 T11791 arg1Of 7D,Figure
R10132 T11793 T11790 arg3Of ),(

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T12343 0-4 RB denotes Thus
T12344 4-5 , denotes ,
T12345 6-13 VBD denotes inhaled
T12346 14-16 NNP denotes FP
T12347 17-18 -LRB- denotes (
T12348 18-21 CD denotes 500
T12349 22-24 NN denotes µg
T12350 24-25 -RRB- denotes )
T12351 26-33 VBD denotes induced
T12352 34-45 JJ denotes significant
T12353 46-50 NN denotes loss
T12354 51-53 IN denotes in
T12355 54-61 JJ denotes nuclear
T12356 62-68 NN denotes GATA-3
T12357 69-71 IN denotes at
T12358 72-73 CD denotes 2
T12359 74-75 NN denotes h
T12360 76-77 -LRB- denotes (
T12361 77-83 JJ denotes median
T12362 84-85 NNP denotes [
T12363 85-87 CD denotes 95
T12364 87-88 NN denotes %
T12365 89-91 NNP denotes CI
T12366 91-92 NNP denotes ]
T12367 92-93 , denotes ,
T12368 94-98 CD denotes 0.40
T12369 99-100 NNP denotes [
T12370 100-104 CD denotes 0.27
T12371 105-109 CD denotes 0.53
T12372 109-110 NNP denotes ]
T12373 111-117 CC denotes versus
T12374 118-122 CD denotes 0.14
T12375 123-124 NNP denotes [
T12376 124-128 CD denotes 0.11
T12377 129-133 CD denotes 0.19
T12378 133-134 NNP denotes ]
T12379 134-135 , denotes ,
T12380 136-137 NN denotes p
T12381 137-138 NN denotes <
T12382 138-142 CD denotes 0.05
T12383 142-143 , denotes ,
T12384 144-145 NNP denotes W
T12385 146-147 SYM denotes =
T12386 148-153 CD denotes 21.00
T12387 153-154 , denotes ,
T12388 155-163 NNP denotes Wilcoxon
T12389 163-165 POS denotes 's
T12390 166-170 NN denotes rank
T12391 171-175 NN denotes test
T12392 175-176 -RRB- denotes )
T12393 177-178 -LRB- denotes (
T12394 178-184 NN denotes Figure
T12395 185-187 NN denotes 7C
T12396 187-188 -RRB- denotes )
T12397 189-192 CC denotes and
T12398 193-204 JJ denotes cytoplasmic
T12399 205-211 NN denotes GATA-3
T12400 212-218 NNS denotes levels
T12401 219-223 VBD denotes were
T12402 224-232 VBN denotes enhanced
T12403 233-235 IN denotes by
T12404 236-243 JJ denotes inhaled
T12405 244-246 NNP denotes FP
T12406 247-249 IN denotes in
T12407 250-251 DT denotes a
T12408 252-266 JJ denotes dose-dependent
T12409 267-273 NN denotes manner
T12410 274-275 -LRB- denotes (
T12411 275-281 JJ denotes median
T12412 282-283 NNP denotes [
T12413 283-285 CD denotes 95
T12414 285-286 NN denotes %
T12415 287-289 NNP denotes CI
T12416 289-290 NNP denotes ]
T12417 290-291 , denotes ,
T12418 292-298 CD denotes 0.0032
T12419 299-300 NNP denotes [
T12420 300-306 CD denotes 0.0026
T12421 307-313 CD denotes 0.0039
T12422 313-314 NNP denotes ]
T12423 315-321 CC denotes versus
T12424 322-327 CD denotes 0.658
T12425 328-329 NNP denotes [
T12426 329-334 CD denotes 0.592
T12427 335-340 CD denotes 0.720
T12428 340-341 NNP denotes ]
T12429 341-342 , denotes ,
T12430 343-344 NN denotes p
T12431 344-345 NN denotes <
T12432 345-349 CD denotes 0.05
T12433 349-350 , denotes ,
T12434 351-352 NNP denotes W
T12435 353-354 SYM denotes =
T12436 355-356 FW denotes −
T12437 356-361 CD denotes 21.00
T12438 361-362 , denotes ,
T12439 363-371 NNP denotes Wilcoxon
T12440 371-373 POS denotes 's
T12441 374-378 NN denotes rank
T12442 379-383 NN denotes test
T12443 383-384 -RRB- denotes )
T12444 385-386 -LRB- denotes (
T12445 386-392 NNP denotes Figure
T12446 393-395 NNP denotes 7D
T12447 395-396 -RRB- denotes )
T12448 396-397 . denotes .
R10656 T12343 T12345 advmod Thus,inhaled
R10657 T12344 T12345 punct ",",inhaled
R10658 T12345 T12345 ROOT inhaled,inhaled
R10659 T12346 T12345 dobj FP,inhaled
R10660 T12347 T12346 punct (,FP
R10666 T12353 T12351 dobj loss,induced
R10667 T12354 T12351 prep in,induced
R10668 T12355 T12356 amod nuclear,GATA-3
R10669 T12356 T12354 pobj GATA-3,in
R10670 T12357 T12351 prep at,induced
R10671 T12358 T12359 nummod 2,h
R10672 T12359 T12357 pobj h,at
R10673 T12360 T12366 punct (,]
R10674 T12361 T12366 amod median,]
R10675 T12362 T12366 compound [,]
R10676 T12363 T12364 nummod 95,%
R10677 T12364 T12366 compound %,]
R10678 T12365 T12366 compound CI,]
R10679 T12366 T12381 meta ],<
R10680 T12367 T12366 punct ",",]
R10681 T12368 T12370 compound 0.40,0.27
R10682 T12369 T12370 compound [,0.27
R10683 T12370 T12366 appos 0.27,]
R10684 T12371 T12372 nummod 0.53,]
R10685 T12372 T12366 conj ],]
R10686 T12373 T12372 cc versus,]
R10687 T12374 T12376 compound 0.14,0.11
R10688 T12375 T12376 compound [,0.11
R10689 T12376 T12366 appos 0.11,]
R10690 T12377 T12378 nummod 0.19,]
R10691 T12378 T12366 appos ],]
R10692 T12379 T12378 punct ",",]
R10693 T12380 T12381 compound p,<
R10694 T12381 T12351 npadvmod <,induced
R10695 T12382 T12381 nummod 0.05,<
R10696 T12383 T12381 punct ",",<
R10697 T12384 T12400 nmod W,levels
R10698 T12385 T12384 punct =,W
R10699 T12386 T12384 appos 21.00,W
R10700 T12387 T12384 punct ",",W
R10701 T12388 T12391 poss Wilcoxon,test
R10702 T12389 T12388 case 's,Wilcoxon
R10703 T12390 T12391 compound rank,test
R10704 T12391 T12384 appos test,W
R10705 T12392 T12384 punct ),W
R10706 T12393 T12395 punct (,7C
R10707 T12394 T12395 compound Figure,7C
R10708 T12395 T12384 appos 7C,W
R10709 T12396 T12395 punct ),7C
R10710 T12397 T12384 cc and,W
R10711 T12398 T12400 amod cytoplasmic,levels
R10712 T12399 T12400 compound GATA-3,levels
R10713 T12400 T12402 nsubjpass levels,enhanced
R10714 T12401 T12402 auxpass were,enhanced
R10715 T12402 T12351 conj enhanced,induced
R10716 T12403 T12402 agent by,enhanced
R10717 T12404 T12405 amod inhaled,FP
R10718 T12405 T12403 pobj FP,by
R10719 T12406 T12402 prep in,enhanced
R10720 T12407 T12409 det a,manner
R10721 T12408 T12409 amod dose-dependent,manner
R10722 T12409 T12406 pobj manner,in
R10723 T12410 T12416 punct (,]
R10724 T12411 T12416 amod median,]
R10725 T12412 T12416 compound [,]
R10726 T12413 T12414 nummod 95,%
R10727 T12414 T12416 compound %,]
R10728 T12415 T12416 compound CI,]
R10729 T12416 T12409 appos ],manner
R10730 T12417 T12416 punct ",",]
R10731 T12418 T12420 nummod 0.0032,0.0026
R10732 T12419 T12420 compound [,0.0026
R10733 T12420 T12416 appos 0.0026,]
R10734 T12421 T12422 nummod 0.0039,]
R10735 T12422 T12416 conj ],]
R10736 T12423 T12422 cc versus,]
R10737 T12424 T12426 compound 0.658,0.592
R10738 T12425 T12426 compound [,0.592
R10739 T12426 T12416 appos 0.592,]
R10740 T12427 T12428 nummod 0.720,]
R10741 T12428 T12416 appos ],]
R10742 T12429 T12428 punct ",",]
R10743 T12430 T12431 compound p,<
R10744 T12431 T12432 compound <,0.05
R10745 T12432 T12428 appos 0.05,]
R10746 T12433 T12428 punct ",",]
R10747 T12434 T12428 amod W,]
R10748 T12435 T12416 punct =,]
R10749 T12436 T12416 punct −,]
R10750 T12437 T12416 appos 21.00,]
R10751 T12438 T12416 punct ",",]
R10752 T12439 T12442 poss Wilcoxon,test
R10753 T12440 T12439 case 's,Wilcoxon
R10754 T12441 T12442 compound rank,test
R10755 T12442 T12416 appos test,]
R10756 T12443 T12416 punct ),]
R10757 T12444 T12446 punct (,7D
R10758 T12445 T12446 compound Figure,7D
R10759 T12446 T12416 appos 7D,]
R10760 T12447 T12416 punct ),]
R10761 T12448 T12345 punct .,inhaled
R10661 T12348 T12349 nummod 500,µg
R10662 T12349 T12346 appos µg,FP
R10663 T12350 T12346 punct ),FP
R10664 T12351 T12345 conj induced,inhaled
R10665 T12352 T12353 amod significant,loss

sentences

Id Subject Object Predicate Lexical cue
T11304 0-397 Sentence denotes Thus, inhaled FP (500 µg) induced significant loss in nuclear GATA-3 at 2 h (median [95% CI], 0.40 [0.27–0.53] versus 0.14 [0.11–0.19], p<0.05, W = 21.00, Wilcoxon's rank test) (Figure 7C) and cytoplasmic GATA-3 levels were enhanced by inhaled FP in a dose-dependent manner (median [95% CI], 0.0032 [0.0026–0.0039] versus 0.658 [0.592–0.720], p<0.05, W = −21.00, Wilcoxon's rank test) (Figure 7D).
T250 0-397 Sentence denotes Thus, inhaled FP (500 µg) induced significant loss in nuclear GATA-3 at 2 h (median [95% CI], 0.40 [0.27–0.53] versus 0.14 [0.11–0.19], p<0.05, W = 21.00, Wilcoxon's rank test) (Figure 7C) and cytoplasmic GATA-3 levels were enhanced by inhaled FP in a dose-dependent manner (median [95% CI], 0.0032 [0.0026–0.0039] versus 0.658 [0.592–0.720], p<0.05, W = −21.00, Wilcoxon's rank test) (Figure 7D).

events-check-again

Id Subject Object Predicate Lexical cue Negation
T12772 26-33 Positive_regulation denotes induced
T12773 46-50 Localization denotes loss true
T12774 54-61 Entity denotes nuclear
T12775 62-68 Protein denotes GATA-3
T12776 193-204 Entity denotes cytoplasmic
T12777 205-211 Protein denotes GATA-3
T12778 212-218 Localization denotes levels
T12779 224-232 Positive_regulation denotes enhanced
T12780 257-266 Regulation denotes dependent
R10996 T12773 T12772 themeOf loss,induced
R10997 T12774 T12773 locationOf nuclear,loss
R10998 T12775 T12773 themeOf GATA-3,loss
R10999 T12776 T12778 locationOf cytoplasmic,levels
R11000 T12777 T12778 themeOf GATA-3,levels
R11001 T12778 T12779 themeOf levels,enhanced
R11002 T12779 T12780 themeOf enhanced,dependent

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T12828 193-211 Protein denotes cytoplasmic GATA-3
T12829 244-246 Protein denotes FP
T12830 54-61 Entity denotes nuclear
T12831 224-232 Positive_regulation denotes enhanced
R11036 T12828 T12831 themeOf cytoplasmic GATA-3,enhanced
R11037 T12829 T12831 causeOf FP,enhanced

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Negation
T11265 26-33 Positive_regulation denotes induced
T11266 46-50 Localization denotes loss true
T11267 54-61 Entity denotes nuclear
T11268 62-68 Protein denotes GATA-3
T11269 193-204 Entity denotes cytoplasmic
T11270 205-211 Protein denotes GATA-3
T11271 212-218 Localization denotes levels
T11272 224-232 Positive_regulation denotes enhanced
T11273 257-266 Regulation denotes dependent
R9625 T11266 T11265 themeOf loss,induced
R9626 T11267 T11266 locationOf nuclear,loss
R9627 T11268 T11266 themeOf GATA-3,loss
R9628 T11269 T11271 locationOf cytoplasmic,levels
R9629 T11270 T11271 themeOf GATA-3,levels
R9630 T11271 T11272 themeOf levels,enhanced
R9631 T11272 T11273 themeOf enhanced,dependent

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T11907 62-68 P23771 denotes GATA-3
T11908 205-211 P23771 denotes GATA-3

test2

Id Subject Object Predicate Lexical cue
T11199 26-33 Positive_regulation denotes induced
T11200 46-50 Negative_regulation denotes loss
T11201 62-68 Protein denotes GATA-3
T11202 205-211 Protein denotes GATA-3
T11203 224-232 Positive_regulation denotes enhanced
R9578 T11200 T11199 themeOf loss,induced
R9579 T11200 T11203 themeOf loss,enhanced
R9580 T11201 T11200 themeOf GATA-3,loss
R9581 T11202 T11203 themeOf GATA-3,enhanced
R9582 T11202 T11200 themeOf GATA-3,loss